Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Mylan Inc.
With
Eligible subjects will be randomly assigned based on predefined stratification factors of weight, geographic region, and presence of psoriatic arthritis: Randomization is 2:1 to MYL-1401A or Humira®, respectively. The study will be conducted in the outpatient setting and comprises 3 periods: a screening period of up to 4 weeks, a 52-week treatment period, and a safety follow-up for 8 weeks. A subject will be considered to have completed the study once they have completed the 52-week treatment period and the 8-week follow-up visit.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted